Featured Research

from universities, journals, and other organizations

Double The Death Rate From Cirrhosis For 'Blue Collar' Men

Date:
May 10, 2007
Source:
University of Queensland
Summary:
Australian manual or "blue collar" workers are dying from liver cirrhosis 2.5 times the rate of their "white collar" counterparts, according to a University of Queensland study.

Australian manual or "blue collar" workers are dying from liver cirrhosis 2.5 times the rate of their "white collar" counterparts, according to a University of Queensland study.

School of Population Health Professors Jake Najman and Gail Williams and Stockholm University's Professor Robin Room examined death rates among Australian men from liver cirrhosis between 1981 and 2002.

Their results were published in the May 2007 edition of the prestigious journal, Drug and Alcohol Review.

The men were categorised according to whether they were manual or non-manual workers. Manual worker status is a marker for lower socio-economic status (SES).

Heavy or binge drinking is one of the main contributors to the development of liver cirrhosis.

Professor Najman said the study results suggested that men from lower socio-economic backgrounds were in greater danger of liver cirrhoses because of their heavy and binge drinking.

Liver cirrhosis accounted for 3.3 percent of all deaths among men aged between 15 and 64 in Australia in 2002 (543) and is the 10th largest overall killer of men.

Cirrhosis is believed to develop in about 15 percent of people who drink heavily for more than a decade -- three to four drinks a day for men and two to three drinks a day for women.

"Lower socio-economic groups appear to have increased their harmful alcohol consumption relative to middle and higher SES groups. This may be due to the increased affordability and availability of alcohol," Professor Najman said.

"In Australia, alcohol has become relatively cheaper and more available.

"It is already known that socio-economic inequalities in alcohol-related diseases are among the largest of any cause of death. For example, in Britain, between 1991 and 1993, liver cirrhosis rates among unskilled workers were about four times those experienced by professionals.

"The very low tax on wine means cask wine is often the beverage of choice for the poorest and most marginalised people."

The study's findings dovetail with another paper recently published in the Bulletin of the World Health Organisation by Professor Najman and co-authors, Dr Ghasem Toloo and Dr Victor Siskind, urging the need for more healthy-living programs targeted at the socioeconomically disadvantaged.

Professor Najman said reducing tobacco use and excessive alcohol consumption among the most socioeconomically disadvantaged should be an urgent national priority.


Story Source:

The above story is based on materials provided by University of Queensland. Note: Materials may be edited for content and length.


Cite This Page:

University of Queensland. "Double The Death Rate From Cirrhosis For 'Blue Collar' Men." ScienceDaily. ScienceDaily, 10 May 2007. <www.sciencedaily.com/releases/2007/05/070509161237.htm>.
University of Queensland. (2007, May 10). Double The Death Rate From Cirrhosis For 'Blue Collar' Men. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2007/05/070509161237.htm
University of Queensland. "Double The Death Rate From Cirrhosis For 'Blue Collar' Men." ScienceDaily. www.sciencedaily.com/releases/2007/05/070509161237.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins